Trump drug pricing order to have limited credit impact on Indian pharma: CRISIL

India’s pharmaceutical sector is expected to weather the impact of the latest U.S. Executive Order aimed at slashing prescription drug prices, according to a credit alert issued by CRISIL Ratings. The order, which introduces a Most Favoured
Read more...